Low-dose aspirin for inflammation and uterine cancer prevention
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether taking a low-dose aspirin daily can reduce inflammation and lower the risk of uterine (endometrial) cancer in postmenopausal women who have pelvic pain and certain uterine changes. If you qualify, you may receive either aspirin or a placebo (inactive pill) to see if aspirin helps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have gone through menopause (no period for over a year, or confirmed by blood tests).
- You have pelvic pain or other symptoms like postmenopausal bleeding or a thickened uterine lining that led your doctor to recommend a uterine biopsy.
- You have not had your uterus removed (hysterectomy).
- Your recent uterine biopsy does not show precancerous or cancerous cells.
- You are willing to provide blood, urine, and tissue samples for research.
- You have no allergy to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a low dose of aspirin after childbirth can lower the chance of developing breast cancer later. You may be asked to provide blood, urine, and breast tissue samples so researchers can look for changes that could explain why aspirin may help.
This trial tests whether taking aspirin after endoscopic removal of an early stomach condition can lower the chance of the cancer coming back or progressing. You may be considered if your early stomach findings were fully removed and you’re able to avoid certain medications that raise bleeding risk.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This study observes patients who need a scope exam or scraping of the uterus to look for conditions like polyps, fibroids, or cancer. It aims to gather information to improve care.
This study is looking at women who have unusual bleeding or bleeding after menopause to find better ways to diagnose reproductive cancers like endometrial cancer. If you are 45 or older and still have your uterus, you may be able to help.
This study tests whether low-dose tamoxifen (a breast cancer prevention drug) or omega-3 supplements can lower breast cancer risk in postmenopausal women who are overweight and have a higher chance of getting the disease. The study lasts about 6 months and involves blood draws and a breast fluid test to see how the treatment affects breast cells.
Hear when a new Endometrial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.